Research Article
Structure Identification and Risk Assurance of Unknown Impurities in Pramipexole Oral Drug Formulation
Figure 11
RMSDCa graphic of pramipexole, pramipexole mannose adduct, and pramipexole ribose adduct in dopamine receptor D3. (a) 50 ns trajectories and (b) 5 ns trajectories.
(a) |
(b) |